Dyne Therapeutics, Inc. ( DYN ) stock has had a pretty rocky 2025. Year to date, the stock is down about 21% and has relied mainly on hitting milestones as big positive catalysts. The way I now seeI hold a Master’s degree in Cell Biology and began my career working for several years as a lab technician in a drug discovery clinic, where I gained extensive hands-on experience in cell culture, assay development, and therapeutic research. That scientific foundation gave me an appreciation for the rigor and chal ...